Literature DB >> 27656018

Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha.

Christian König1, Eric Morch1, Annett Eitner1, Christian Möller1, Brian Turnquist2, Hans-Georg Schaible1, Andrea Ebersberger3.   

Abstract

UNLABELLED: During peripheral inflammation, both spinal TNF-α and IL-6 are released within the spinal cord and support the generation of inflammation-evoked spinal hyperexcitability. However, whether spinal TNF-α and IL-6 act independently in parallel or in a functionally dependent manner has not been investigated. In extracellular recordings from mechanonociceptive deep dorsal horn neurons of normal rats in vivo, we found that spinal application of TNF-α increased spinal neuronal responses to mechanical stimulation of knee and ankle joints. This effect was significantly attenuated by either sgp130, which blocks IL-6 trans-signaling mediated by IL-6 and its soluble receptor IL-6R (sIL-6R); by an antibody to the IL-6 receptor; or by minocycline, which inhibits the microglia. IL-6 was localized in neurons of the spinal cord and, upon peripheral noxious stimulation in the presence of spinal TNF-α, IL-6 was released spinally. Furthermore, TNF-α recruited microglial cells to provide sIL-6R, which can form complexes with IL-6. Spinal application of IL-6 plus sIL-6R, but not of IL-6 alone, enhanced spinal hyperexcitability similar to TNF-α and the inhibition of TNF-α-induced hyperexcitability by minocycline was overcome by coadministration of sIL-6R, showing that sIL-6R is required. Neither minocycline nor the TNF-α-neutralizing compound etanercept inhibited the induction of hyperexcitability by IL-6 plus sIL-6R. Together, these data show that the induction of hyperexcitability of nociceptive deep dorsal horn neurons by TNF-α largely depends on the formation of IL-6/sIL-6R complexes that are downstream of TNF-α and requires the interactions of neurons and microglia orchestrated by TNF-α. SIGNIFICANCE STATEMENT: Both spinal TNF-α and IL-6 induce a state of spinal hyperexcitability. We present the novel finding that the full effect of TNF-α on the development of spinal hyperexcitability depends on IL-6 trans-signaling acting downstream of TNF-α. IL-6 trans-signaling requires the formation of complexes of IL-6 and soluble IL-6 receptor. Spinal TNF-α furthers the release of IL-6 from neurons in the spinal cord during peripheral noxious stimulation and recruits microglial cells to provide soluble IL-6 receptor, which can form complexes with IL-6. Therefore, a specific interaction between neurons and microglia is required for the full development of TNF-α-induced hyperexcitability of nociceptive deep horsal horn neurons.
Copyright © 2016 the authors 0270-6474/16/369782-10$15.00/0.

Entities:  

Keywords:  central sensitization; cytokine; electrophysiology; inflammation; microglia; soluble IL-6 receptor

Mesh:

Substances:

Year:  2016        PMID: 27656018      PMCID: PMC6705568          DOI: 10.1523/JNEUROSCI.4159-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130.

Authors:  Mari A Nowell; Peter J Richards; Sankichi Horiuchi; Naoki Yamamoto; Stefan Rose-John; Nicholas Topley; Anwen S Williams; Simon A Jones
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

2.  Neural spike classification using parallel selection of all algorithm parameters.

Authors:  Brian Turnquist; Mark Leverentz; Erin Swanson
Journal:  J Neurosci Methods       Date:  2004-08-30       Impact factor: 2.390

Review 3.  Role of the immune system in chronic pain.

Authors:  Fabien Marchand; Mauro Perretti; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2005-07       Impact factor: 34.870

4.  CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.

Authors:  F Padberg; W Feneberg; S Schmidt; M J Schwarz; D Körschenhausen; B D Greenberg; T Nolde; N Müller; H Trapmann; N König; H J Möller; H Hampel
Journal:  J Neuroimmunol       Date:  1999-10-29       Impact factor: 3.478

5.  Adjuvant-induced arthritis: IL-1 beta, IL-6 and TNF-alpha are up-regulated in the spinal cord.

Authors:  L Bao; Y Zhu; A M Elhassan; Q Wu; B Xiao; J Zhu; J U Lindgren
Journal:  Neuroreport       Date:  2001-12-21       Impact factor: 1.837

Review 6.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

7.  Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

Authors:  T Jostock; J Müllberg; S Ozbek; R Atreya; G Blinn; N Voltz; M Fischer; M F Neurath; S Rose-John
Journal:  Eur J Biochem       Date:  2001-01

8.  Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS.

Authors:  Vasudeva Raghavendra; Flobert Y Tanga; Joyce A DeLeo
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

Review 9.  Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity.

Authors:  Eric Jüttler; Victoria Tarabin; Markus Schwaninger
Journal:  Neuroscientist       Date:  2002-06       Impact factor: 7.519

Review 10.  Microglia as a source and target of cytokines.

Authors:  Uwe-Karsten Hanisch
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  13 in total

Review 1.  [Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases].

Authors:  H-G Schaible; H-D Chang; S Grässel; H Haibel; A Hess; T Kamradt; A Radbruch; G Schett; C Stein; R H Straub
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

2.  IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level RORγt Expression.

Authors:  Bofeng Li; Lindsay L Jones; Terrence L Geiger
Journal:  J Immunol       Date:  2018-10-12       Impact factor: 5.422

3.  Spinal Inhibition of P2XR or p38 Signaling Disrupts Hyperalgesic Priming in Male, but not Female, Mice.

Authors:  Candler Paige; Gayathri Batchalli Maruthy; Galo Mejia; Gregory Dussor; Theodore Price
Journal:  Neuroscience       Date:  2018-06-18       Impact factor: 3.590

Review 4.  Mechanisms of Osteoarthritic Pain. Studies in Humans and Experimental Models.

Authors:  Annett Eitner; Gunther O Hofmann; Hans-Georg Schaible
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

5.  Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain.

Authors:  Rui Zhou; Tao Xu; XiaoHong Liu; YuanShou Chen; DeYing Kong; Hong Tian; Mingxia Yue; Dujuan Huang; Junwei Zeng
Journal:  J Pain Res       Date:  2018-03-27       Impact factor: 3.133

6.  The combination of postnatal maternal separation and social stress in young adulthood does not lead to enhanced inflammatory pain sensitivity and depression-related behavior in rats.

Authors:  Julien Genty; Milène Tetsi Nomigni; Fernand Anton; Ulrike Hanesch
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

7.  VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis.

Authors:  Nicholas Beazley-Long; Catherine Elizabeth Moss; William Robert Ashby; Samuel Marcus Bestall; Fatimah Almahasneh; Alexandra Margaret Durrant; Andrew Vaughan Benest; Zoe Blackley; Kurt Ballmer-Hofer; Masanori Hirashima; Richard Phillip Hulse; David Owen Bates; Lucy Frances Donaldson
Journal:  Brain Behav Immun       Date:  2018-03-14       Impact factor: 7.217

8.  Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice.

Authors:  Petra Huehnchen; Hannah Muenzfeld; Wolfgang Boehmerle; Matthias Endres
Journal:  Cell Death Dis       Date:  2020-01-22       Impact factor: 8.469

9.  Primary culture of the rat spinal dorsal horn: a tool to investigate the effects of inflammatory stimulation on the afferent somatosensory system.

Authors:  Stephan Leisengang; Franz Nürnberger; Daniela Ott; Jolanta Murgott; Rüdiger Gerstberger; Christoph Rummel; Joachim Roth
Journal:  Pflugers Arch       Date:  2020-10-24       Impact factor: 3.657

10.  Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain - Study protocol for a randomized double-blind controlled study.

Authors:  H M Schenker; K Tascilar; L Konerth; M Sergeeva; J Prade; S Strobelt; A Kleyer; D Simon; L Mendez; M Hagen; V Schönau; A Hueber; J Roesch; A Dörfler; A Hess; G Schett; J Rech
Journal:  Contemp Clin Trials Commun       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.